In a pan-cancer analysis, a broad variety of cancer types were shown to downregulate circadian gene expression, causing a direct regulatory effect on PD-L1 expression and perpetuating an immunosuppressive tumor phenotype [72]. The gene discussed is CD274; the disease is neoplasm.